Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
María J. Cancelo, Rafael Sánchez Borrego, Santiago Palacios, Laura Baquedano, Tanit Corbacho Garza, Noelia Fernández Aller, Carmen García Ferreiro, Juan José Quijano Martín & A. Javier González Calvo. (2023) Vulvovaginal atrophy in the CRETA study: the healthcare professionals’ perception. Gynecological Endocrinology 39:1.
Read now
Read now
S. Palacios, R. E. Nappi, M. J. Cancelo, S. Sánchez & T. Simoncini. (2023) Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence. Climacteric 26:4, pages 388-391.
Read now
Read now
Articles from other publishers (2)
Maria Cristina Meriggiola, Paola Villa, Silvia Maffei, Angelamaria Becorpi, Tiziana Di Paolantonio, Antonio Nicolucci, Stefano Salvatore & Rossella E. Nappi. (2024) Vulvovaginal atrophy in women with and without a history of breast cancer: Baseline data from the PatiEnt satisfactiON studY (PEONY) in Italy. Maturitas, pages 107950.
Crossref
Crossref
Santiago Palacios, Rafael Sánchez-Borrego, Beatriz Suárez Álvarez, Félix Lugo Salcedo, A. Javier González Calvo, Juan José Quijano Martín, María J. Cancelo & María Fasero. (2023) Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale. Maturitas 172, pages 46-51.
Crossref
Crossref